22.418 articles found

Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivatives

GALLEY GUIDO, ZBINDEN KATRIN GROEBKE, HOENER MARIUS, KOLCZEWSKI SABINE, NORCROSS ROGER, STALDER HENRI.

· 2007-01-19

USE OF 2-IMIDAZOLES FOR THE TREATMENT OF CNS DISORDERS

GALLEY GUIDO, GROEBKE ZBINDEN KATRIN, NORCROSS ROGER, STALDER HENRI.

· 2007-01-17

USE OF 2-IMIDAZOLES FOR THE TREATMENT OF CNS DISORDERS

HOENER MARIUS, KOLCZEWSKI SABINE, STALDER HENRI.

· 2007-01-17

Use of 2-imidazoles for the treatment of CNS disorders

MARIUS HOENER, SABINE KOLCZEWSKI, HENRI STALDER.

· 2007-01-17

Use of 2-imidazoles for the treatment of CNS disorders

GUIDO GALLEY, KATRIN GROEBKE ZBINDEN, ROGER NORCROSS, HENRI STALDER.

· 2007-01-17

USE OF COMPOUNDS IN THE TREATMENT OF ISCHEMIA AND NEURODEGENERATION

GLAS RICKARD, XU HONG.

· 2007-01-15

Use of tpp ii inhibitors in combination with gamma-irradiation for the treatment of cancer

RICKARD GLAS, HONG XU.

· 2007-01-15

METHOD AND COMPOSITION FOR THE TREATMENT OF PARKINSON'S DISEASE

ZHU BAO TING.

· 2007-01-12

Method and Composition for the Treatment of Parkinson's Disease

ZHU BAO TING.

· 2007-01-12

Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.

Splinter MY.

Ann Pharmacother · 2007-01-09

DOI: 10.1345/aph.1h113PMID: 17213296

Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease.

Androulidakis AG, Kühn AA, Chen CC, Blomstedt P, Kempf F, Kupsch A, Schneider GH, Doyle L, Dowsey-Limousin P, Hariz MI, Brown P.

Brain · 2007-01-08

DOI: 10.1093/brain/awl358PMID: 17213215

Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients.

Arbouw ME, Movig KL, Neef C, Guchelaar HJ, Egberts TC.

Eur J Clin Pharmacol · 2007-01-03

DOI: 10.1007/s00228-006-0233-9PMID: 17200834